€65m bid to develop Alzheimer’s treatment

A new approach to developing Alzheimer’s drugs is at the heart of a €65m European research project which could mark a turning point in the fight against the disease.

Scientists led by a team from the University of Edinburgh will attempt to find reliable biomarkers in patients that can be used to spot very early signs of the disease.

At the same time another arm of the study, running in parallel, will look for drugs that might help those individuals at highest risk.